CXCR‐4 Targeted, Short Wave Infrared (SWIR) Emitting Nanoprobes for Enhanced Deep Tissue Imaging and Micrometastatic Cancer Lesion Detection
Margot Zevon(Rutgers, The State University of New Jersey), Prabhas V. Moghe(Rutgers, The State University of New Jersey), Harini Kantamneni(Rutgers, The State University of New Jersey), Mei Chee Tan(Singapore University of Technology and Design), Marco Mingozzi(Rutgers, The State University of New Jersey), Mark C. Pierce(Rutgers, The State University of New Jersey), Richard E. Riman(Rutgers, The State University of New Jersey), Sheng Yang(Singapore University of Technology and Design), Charles M. Roth, Paul Kim(Korea University Medical Center), Vidya Ganapathy(Rutgers Cancer Institute of New Jersey), Derek Adler(Imaging Center)
Cited by 63
Related Papers
Survivin and molecular pathogenesis of colorectal cancer
|The Lancet|2003|322
Inhibition of melanoma tumor growth <i>in vivo</i> by survivin targeting
|Proceedings of the National Academy of Sciences|2001|285
Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53
|Journal of Clinical Investigation|2001|194
Autophagy Regulation of Metabolism Is Required for CD8+ T Cell Anti-tumor Immunity
|Cell Reports|2019|182
Targeting the Transforming Growth Factor-β pathway inhibits human basal-like breast cancer metastasis
|Molecular Cancer|2010|165